Scrip
Updated US hepatic warnings for all diclofenac sodium products
10 December 2009
Nancy Faigen
The prescribing information for all diclofenac-containing products in the US has been updated at the request of the
US FDA. The update pertains to expanded warnings and precautions on the risk of elevations in liver enzymes during treatment.
Products affected include Voltaren and Voltaren Gel....
Please Login to read the full article.
10 December 2009
Nancy Faigen
Products affected include Voltaren and Voltaren Gel....
Please Login to read the full article.
RELATED CONTENT
NEWS
- Isis's mipomersen passes second Phase III trial, but safety concerns spook investors
- FDA panel recommends Recordati's carglumic acid for rare disease
- InterMune reports positive interim Phase II data for hepatitis C protease inhibitor
- Novartis turns down Idenix's lead HCV candidate
ANALYSIS
- Mind over matter - innovation in Parkinson's continues apace
- Executive Briefing – Brazil emerges as a saviour for pharma
COMMENT
Other Informa Comment
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
